ID

27973

Beschrijving

NCT02499003 The GOAL Trial: Rescue Treatment With the Monoclonal Anti CD20-antibody Obinutuzumab (GA101) in Combination With Pixantrone for the Treatment of Patients With Relapsed Aggressive B-cell Lymphoma. Visit: End of Treatment. Quelle: Prof. Dr. med. Georg Heß Universitätsmedizin Mainz

Trefwoorden

  1. 07/12/2017 07/12/2017 -
  2. 01/01/2018 01/01/2018 -
Houder van rechten

Prof. Dr. med. Georg Heß

Geüploaded op

7 de dezembro de 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :


Geen commentaren

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

End of Treatment GOAL Trial B-cell Lymphoma NCT02499003

End of Treatment GOAL Trial B-cell Lymphoma NCT02499003

End of Treatment
Beschrijving

End of Treatment

Subject-ID
Beschrijving

Subject ID

Datatype

text

Alias
UMLS CUI [1]
C2348585 (Clinical Trial Subject Unique Identifier)
Did the subject complete the treatment cycles?
Beschrijving

completion treatment cycles

Datatype

boolean

If 'no', please specify reason(s) for early treatment termination: Progression of underlying disease
Beschrijving

Progression of underlying disease

Datatype

boolean

If 'no', please specify reason(s) for early treatment termination: Adverse event
Beschrijving

Adverse event

Datatype

boolean

If 'Adverse Event', please specify:
Beschrijving

Adverse event specification

Datatype

text

If 'no', please specify reason(s) for early treatment termination: Death
Beschrijving

Death

Datatype

boolean

If 'no', please specify reason(s) for early treatment termination: Withdrawal of consent
Beschrijving

Withdrawal of consent

Datatype

boolean

If 'no', please specify reason(s) for early treatment termination: Non-compliance with protocol
Beschrijving

Non-compliance with protocol

Datatype

boolean

If 'Non-compliance with protocol', please specify:
Beschrijving

Non-compliance with protocol specification

Datatype

text

If 'no', please specify reason(s) for early treatment termination: Other
Beschrijving

Other reason early treatment termination

Datatype

boolean

If 'Other', please specify:
Beschrijving

Other reason early termination specification

Datatype

text

Similar models

End of Treatment GOAL Trial B-cell Lymphoma NCT02499003

Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
End of Treatment
Subject ID
Item
Subject-ID
text
C2348585 (UMLS CUI [1])
completion treatment cycles
Item
Did the subject complete the treatment cycles?
boolean
Progression of underlying disease
Item
If 'no', please specify reason(s) for early treatment termination: Progression of underlying disease
boolean
Adverse event
Item
If 'no', please specify reason(s) for early treatment termination: Adverse event
boolean
Adverse event specification
Item
If 'Adverse Event', please specify:
text
Death
Item
If 'no', please specify reason(s) for early treatment termination: Death
boolean
Withdrawal of consent
Item
If 'no', please specify reason(s) for early treatment termination: Withdrawal of consent
boolean
Non-compliance with protocol
Item
If 'no', please specify reason(s) for early treatment termination: Non-compliance with protocol
boolean
Non-compliance with protocol specification
Item
If 'Non-compliance with protocol', please specify:
text
Other reason early treatment termination
Item
If 'no', please specify reason(s) for early treatment termination: Other
boolean
Other reason early termination specification
Item
If 'Other', please specify:
text

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial